Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF: PFRM3)
Brazil
· Delayed Price · Currency is BRL 6.15
-0.03 (-0.49%)
Sep 11, 2024, 4:50 PM GMT-3
PFRM3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 9,038 | 8,662 | 7,816 | 6,413 | 5,481 | 4,801 | Upgrade
|
| Revenue Growth (YoY) | 9.02% | 10.82% | 21.88% | 17.00% | 14.16% | 12.41% | Upgrade
|
| Cost of Revenue | 7,657 | 7,370 | 6,671 | 5,506 | 4,718 | 4,063 | Upgrade
|
| Gross Profit | 1,381 | 1,292 | 1,146 | 907.57 | 763.57 | 737.84 | Upgrade
|
| Selling, General & Admin | 1,111 | 1,046 | 916.83 | 668.28 | 567 | 555.97 | Upgrade
|
| Other Operating Expenses | -16.4 | -15.5 | -14.27 | -9.64 | -23.31 | -5.07 | Upgrade
|
| Operating Expenses | 1,095 | 1,031 | 902.56 | 771.32 | 635.29 | 632.39 | Upgrade
|
| Operating Income | 286.48 | 261.12 | 242.95 | 136.25 | 128.28 | 105.45 | Upgrade
|
| Interest Expense | -157.57 | -161.9 | -149.2 | -76.16 | -67.22 | -93.13 | Upgrade
|
| Interest & Investment Income | 8.4 | 10.95 | 8.68 | 4.9 | 4.26 | 3.22 | Upgrade
|
| Earnings From Equity Investments | 0.02 | 0.01 | -0.01 | 5.98 | 4.1 | 2.59 | Upgrade
|
| Other Non Operating Income (Expenses) | -24.53 | -28.59 | -23.46 | -10.71 | -24.53 | -13.48 | Upgrade
|
| EBT Excluding Unusual Items | 112.79 | 81.59 | 78.97 | 60.26 | 44.89 | 4.66 | Upgrade
|
| Impairment of Goodwill | - | - | - | -11.52 | -11.74 | -47.09 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 63.99 | Upgrade
|
| Pretax Income | 112.79 | 81.59 | 78.97 | 48.75 | 33.15 | 21.56 | Upgrade
|
| Income Tax Expense | 13.16 | 3.74 | -6.07 | -30.37 | -28.65 | 9.58 | Upgrade
|
| Earnings From Continuing Operations | 99.64 | 77.86 | 85.04 | 79.11 | 61.8 | 11.98 | Upgrade
|
| Minority Interest in Earnings | -9.05 | -7.46 | -4.17 | -0.92 | -9.46 | - | Upgrade
|
| Net Income | 90.58 | 70.4 | 80.87 | 78.19 | 52.33 | 11.98 | Upgrade
|
| Net Income to Common | 90.58 | 70.4 | 80.87 | 78.19 | 52.33 | 11.98 | Upgrade
|
| Net Income Growth | 194.91% | -12.95% | 3.43% | 49.41% | 336.92% | - | Upgrade
|
| Shares Outstanding (Basic) | 123 | 123 | 123 | 123 | 123 | 123 | Upgrade
|
| Shares Outstanding (Diluted) | 123 | 123 | 123 | 123 | 123 | 123 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | - | 4.67% | Upgrade
|
| EPS (Basic) | 0.74 | 0.57 | 0.66 | 0.64 | 0.43 | 0.10 | Upgrade
|
| EPS (Diluted) | 0.74 | 0.57 | 0.66 | 0.64 | 0.43 | 0.10 | Upgrade
|
| EPS Growth | 194.92% | -12.98% | 3.43% | 49.41% | 336.92% | - | Upgrade
|
| Free Cash Flow | 487.44 | 193.37 | 66.37 | 39.04 | 3.3 | 106.17 | Upgrade
|
| Free Cash Flow Per Share | 3.98 | 1.58 | 0.54 | 0.32 | 0.03 | 0.87 | Upgrade
|
| Dividend Per Share | 0.116 | 0.116 | 0.173 | 0.271 | - | - | Upgrade
|
| Dividend Growth | -33.23% | -33.23% | -35.94% | - | - | - | Upgrade
|
| Gross Margin | 15.28% | 14.92% | 14.66% | 14.15% | 13.93% | 15.37% | Upgrade
|
| Operating Margin | 3.17% | 3.01% | 3.11% | 2.12% | 2.34% | 2.20% | Upgrade
|
| Profit Margin | 1.00% | 0.81% | 1.03% | 1.22% | 0.95% | 0.25% | Upgrade
|
| Free Cash Flow Margin | 5.39% | 2.23% | 0.85% | 0.61% | 0.06% | 2.21% | Upgrade
|
| EBITDA | 316.77 | 295.65 | 273.34 | 162.72 | 149.91 | 126.54 | Upgrade
|
| EBITDA Margin | 3.50% | 3.41% | 3.50% | 2.54% | 2.73% | 2.64% | Upgrade
|
| D&A For EBITDA | 30.29 | 34.52 | 30.38 | 26.47 | 21.64 | 21.09 | Upgrade
|
| EBIT | 286.48 | 261.12 | 242.95 | 136.25 | 128.28 | 105.45 | Upgrade
|
| EBIT Margin | 3.17% | 3.01% | 3.11% | 2.12% | 2.34% | 2.20% | Upgrade
|
| Effective Tax Rate | 11.67% | 4.58% | - | - | - | 44.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.